US 7919095
Anti-IL-6 monoclonal antibodies
granted A61PA61P19/02A61P29/00
Quick answer
US patent 7919095 (Anti-IL-6 monoclonal antibodies) held by VACCINEX, INC. expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P19/02, A61P29/00, A61P35/00, A61P35/02